Anti-IKZF1 monoclonal antibody

Pre-made anti-IKZF1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to IKZF1/IKZF1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1008-Ab-1/ GM-Tg-hg-IP1008-Ab-2Anti-Human IKZF1 monoclonal antibodyHuman
GM-Tg-rg-IP1008-Ab-1/ GM-Tg-rg-IP1008-Ab-2Anti-Rat IKZF1 monoclonal antibodyRat
GM-Tg-mg-IP1008-Ab-1/ GM-Tg-mg-IP1008-Ab-2Anti-Mouse IKZF1 monoclonal antibodyMouse
GM-Tg-cynog-IP1008-Ab-1/ GM-Tg-cynog-IP1008-Ab-2Anti-Cynomolgus/ Rhesus macaque IKZF1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1008-Ab-1/ GM-Tg-felg-IP1008-Ab-2Anti-Feline IKZF1 monoclonal antibodyFeline
GM-Tg-cang-IP1008-Ab-1/ GM-Tg-cang-IP1008-Ab-2Anti-Canine IKZF1 monoclonal antibodyCanine
GM-Tg-bovg-IP1008-Ab-1/ GM-Tg-bovg-IP1008-Ab-2Anti-Bovine IKZF1 monoclonal antibodyBovine
GM-Tg-equg-IP1008-Ab-1/ GM-Tg-equg-IP1008-Ab-2Anti-Equine IKZF1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1008-Ab-1/ GM-Tg-hg-IP1008-Ab-2; GM-Tg-rg-IP1008-Ab-1/ GM-Tg-rg-IP1008-Ab-2;
GM-Tg-mg-IP1008-Ab-1/ GM-Tg-mg-IP1008-Ab-2; GM-Tg-cynog-IP1008-Ab-1/ GM-Tg-cynog-IP1008-Ab-2;
GM-Tg-felg-IP1008-Ab-1/ GM-Tg-felg-IP1008-Ab-2; GM-Tg-cang-IP1008-Ab-1/ GM-Tg-cang-IP1008-Ab-2;
GM-Tg-bovg-IP1008-Ab-1/ GM-Tg-bovg-IP1008-Ab-2; GM-Tg-equg-IP1008-Ab-1/ GM-Tg-equg-IP1008-Ab-2
Products NameAnti-IKZF1 monoclonal antibody
Formatmab
Target NameIKZF1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-IKZF1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1008-Ag-1Recombinant multi-species IKZF1/ CVID13/ Hs.54452 protein
    ORF Viral VectorpGMAP000221Human IKZF1 Adenovirus plasmid
    ORF Viral VectorvGMAP000221Human IKZF1 Adenovirus particle
    ORF Viral VectorpGMLPm001762mouse Ikzf1 Lentivirus plasmid
    ORF Viral VectorvGMLPm001762mouse Ikzf1 Lentivirus particle


    Target information

    Target IDGM-IP1008
    Target NameIKZF1
    Gene ID10320,22778,305501,693936,483231,101085701,541154,100052437
    Gene Symbol and Synonyms5832432G11Rik,CVID13,hlk-1,Hs.54452,IK1,IKAROS,IKZF1,LyF-1,LYF1,mKIAA4227,PPP1R92,PRO0758,RGD1562979,Zfpn1a1,ZNFN1A1
    Uniprot AccessionQ13422
    Uniprot Entry NameIKZF1_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000185811
    Target ClassificationTumor-associated antigen (TAA)

    The target: IKZF1, gene name: IKZF1, also named as CVID13, Hs.54452, IK1, IKAROS, LYF1, LyF-1, PPP1R92, PRO0758, ZNFN1A1. This gene encodes a transcription factor that belongs to the family of zinc-finger DNA-binding proteins associated with chromatin remodeling. The expression of this protein is restricted to the fetal and adult hemo-lymphopoietic system, and it functions as a regulator of lymphocyte differentiation. Several alternatively spliced transcript variants encoding different isoforms have been described for this gene. Most isoforms share a common C-terminal domain, which contains two zinc finger motifs that are required for hetero- or homo-dimerization, and for interactions with other proteins. The isoforms, however, differ in the number of N-terminal zinc finger motifs that bind DNA and in nuclear localization signal presence, resulting in members with and without DNA-binding properties. Only a few isoforms contain the requisite three or more N-terminal zinc motifs that confer high affinity binding to a specific core DNA sequence element in the promoters of target genes. The non-DNA-binding isoforms are largely found in the cytoplasm, and are thought to function as dominant-negative factors. Overexpression of some dominant-negative isoforms have been associated with B-cell malignancies, such as acute lymphoblastic leukemia (ALL). [provided by RefSeq, May 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.